Search results for "hypertrophic"

showing 10 items of 42 documents

Hypertrophic cardiomyopathy associated with polyarteritis nodosa: A case of sudden cardiac death

2018

This case concerns a rare sudden cardiac death characterized by macroscopic and microscopic postmortem findings of hypertrophic cardiomyopathy and polyarteritis nodosa. A complete autopsy was carried out, and histological and histochemical methods were employed. The cause of death was acute multifocal ischemic myocitolitic damage caused by both myocardial structural alteration attributable to hypertrophic cardiomyopathy (widespread interstitial fibrosis and multifocal myocyte disarray) and coronary arteritis attributable to polyarteritis nodosa. This is the first case in which the cause of death was attributed to both diseases.

Polyarteritis-NodosaSudden cardiac deathCase reportHypertrophic CardiomyopathyForensic pathology
researchProduct

Management and Outcome of Mucosal Injury During Pyloromyotomy--An Analytical Survey Study.

2015

Different approaches of dealing with mucosal injury during pyloromyotomy for hypertrophic pyloric stenosis have been described. There is, however, no consensus on the best technique to use. We conducted a survey among International Pediatric Endosurgery Group (IPEG) members on their experience of mucosal injuries during pyloromyotomy, the way in which these were handled, any modification in subsequent postoperative care, and impact on outcome.A confidential survey was sent to IPEG members querying demographic data, number of pyloromyotomies performed, operative approach, incidence of mucosal injury, intraoperative management, and postoperative consequences. Statistical analysis was performe…

Postoperative Caremedicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.medical_treatmentMEDLINESurvey researchPyloric Stenosis HypertrophicPyloromyotomyPylorusmedicine.diseasePyloric stenosisSurgerymedicine.anatomical_structureGastric MucosaIntraoperative managementHealth Care SurveysmedicineHumansSurgeryPractice Patterns Physicians'businessIntraoperative ComplicationsHypertrophic Pyloric StenosisPylorusJournal of laparoendoscopicadvanced surgical techniques. Part A
researchProduct

Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review

2021

Hypertrophic cardiomyopathy (HCM) is the most common form of hereditary cardiomyopathy. It is characterized by an unexplained non-dilated hypertrophy of the left ventricle with a conserved or elevated ejection fraction. It is a genetically heterogeneous disease largely caused by variants of genes encoding for cardiac sarcomere proteins, including MYH7, MYBPC3, ACTC1, TPM1, MYL2, MYL3, TNNI3, and TNNT23. Preclinical evidence indicates that the enhanced calcium sensitivity of the myofilaments plays a key role in the pathophysiology of HCM. Notably, this is not always a direct consequence of sarcomeric variations but may also result from secondary mutation-driven alterations. Long non-coding R…

QH301-705.5CardiomyopathyTPM1ReviewBiologyCatalysisInorganic ChemistrymedicineHumansBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyGeneticslong non-coding RNAgenetic variantsOrganic ChemistryACTC1Hypertrophic cardiomyopathyGeneral MedicineCardiomyopathy Hypertrophichypertrophic cardiomyopathymedicine.diseaseLong non-coding RNAcardiovascular diseasesComputer Science ApplicationsChemistryMYL3Cardiovascular diseases Genetic variants Hypertrophic cardiomyopathy Long non-coding RNA Cardiomyopathy Hypertrophic Humans RNA Long NoncodingMYL2RNA Long NoncodingMYH7International Journal of Molecular Sciences
researchProduct

Left ventricular hypertrophy or storage disease? the incremental value of speckle tracking strain bull's-eye

2017

Left ventricular hypertrophy (LVH) develops in response to a variety of physical, genetic, and biochemical stimuli and represents the early stage of ventricular remodeling. In patients with LVH, subclinical left ventricular (LV) dysfunction despite normal ejection fraction (EF) may be present before the onset of symptoms, which portends a dismal prognosis. Strain measurement with two-dimensional speckle tracking echocardiography (STE) represents a highly reproducible and accurate alternative to LVEF determination. The present review focuses on current available evidence that supports the incremental value of STE in the diagnostic and prognostic workup of LVH. When assessing the components o…

Radiology Nuclear Medicine and ImagingSpeckle tracking echocardiographyDisease030204 cardiovascular system & hematologyLeft ventricular hypertrophytwo-dimensional strain0302 clinical medicineCardiomegaly Exercise-Induced030212 general & internal medicineanabolic steroidSubclinical infectionamyloidosiEvidence-Based MedicineEjection fractionHypertrophic cardiomyopathyleft ventricular hypertrophyEchocardiographyCardiologyElasticity Imaging TechniquesHypertrophy Left VentricularRadiologyCardiomyopathiesCardiology and Cardiovascular MedicineHumanendocrine systemmedicine.medical_specialtyarterial hypertensionReproducibility of ResultSensitivity and SpecificityDiagnosis Differential03 medical and health sciencesElasticity Imaging TechniqueInternal medicinemedicineathlete's heartHumanscardiovascular diseasesVentricular remodelingspeckle tracking echocardiographyCardiomyopathiebusiness.industryReproducibility of ResultsStroke Volumeaortic stenosiImage Enhancementmedicine.diseasehypertrophic cardiomyopathyDifferential diagnosisMetabolism Inborn ErrorbusinessMetabolism Inborn Errors
researchProduct

Cardiac magnetic resonance in the assessment of hypertrophic cardiomyopathy phenotypes and stages : pictorial review

2021

The aim of this paper is to present recent advances in hypertrophic cardiomyopathy (HCM) diagnosis and treatment based on a literature review. Special emphasis has been placed on the role of cardiac magnetic resonance imaging (CMR) for the assessment of morphological and functional consequences of different stages of HCM including prognostication. The text is illustrated with the images and data of the HCM patients diagnosed with CMR study in our hospital. CMR is an important tool, particularly relevant in novel risk factors and LV dysfunction groups. The HCM group with overt left ventricular dysfunction is underrecognized, often labelled by clinicians as dilated cardiomyopathy. Advanced di…

Review Paperphenotypecardiovascular systemmagnetic resonance imaginghypertrophicmacromolecular substancescardiovascular diseasescardiomyopathy
researchProduct

Esophageal achalasia and hypertrophic pyloric stenosis associated with a phytobezoar in an adolescent.

2002

Esophageal achalasia is an uncommon condition in children. The authors report on a 14-year-old girl who showed a very unusual association of cardiospasm and hypertrophic pyloric stenosis with a gastric phytobezoar.

medicine.medical_specialtyAdolescentAchalasiaGastroenterologyPyloric StenosisBezoarsInternal medicineotorhinolaryngologic diseasesMedicineHumansEsophagusHypertrophic Pyloric Stenosisbusiness.industryEsophageal diseaseCardiospasmGeneral MedicineHypertrophymedicine.diseasePylorusdigestive system diseasesSurgeryEsophageal AchalasiaStenosismedicine.anatomical_structurePediatrics Perinatology and Child HealthPhytobezoarSurgeryFemalebusinessDeglutition DisordersJournal of pediatric surgery
researchProduct

Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?

2011

Clinical evidence and the recent decisions of the European Medicines Agency and the Food and Drug Administration challenge the safety of thiazolidinediones treatment. Recently, this treatment has been suggested for Friedreich's ataxia because thiazolidinediones improve neurological symptoms. Hypertrophic cardiomyopathy is the most prevalent cardiac feature and the cause of premature death in Friedreich's ataxia patients. We recommend that therapy with peroxisome proliferator-activated receptor-gamma agonists like thiazolidinediones be taken with caution, as they cause a decrease in the number of fast fibers and an increase in mitochondrial biogenesis in cardiac muscle because of the inducti…

medicine.medical_specialtyAtaxiaHeart diseasebusiness.industryInsulinmedicine.medical_treatmentHypertrophic cardiomyopathymedicine.diseaseBioinformaticsEndocrinologyNeurologyMitochondrial biogenesisHeart failureInternal medicinemedicineNeurology (clinical)medicine.symptomRosiglitazonebusinessPioglitazonemedicine.drugMovement Disorders
researchProduct

Laser in surgical scar clearance : an update review

2021

Scar formation is a consequence of wound healing that developed from damaged tissue either from physical injury or surgical incision. A hypertrophic scar develops due to an abnormal healing response to trauma. It might lead to serious functional and cosmetic disability. There are numerous methods mentioned in the literature to treat such scars but to date, no single method has been known to cure them. In this review, we focused on differences between various types of nonsurgical management of hypertrophic scar focusing on the indication, mechanism of action, and efficacy of the pulsed dye laser (PDL), fractional carbon dioxide laser (fCO2), Er-YAG laser, and intense pulse light (IPL). The l…

medicine.medical_specialtyCicatrix Hypertrophicmedicine.medical_treatment610 MedizinLasers DyeScarsLasers Solid-StateDermatologyCicatrixHypertrophic scar610 Medical sciencesHumansMedicineSurgical scarWound Healingbusiness.industryCarbon dioxide lasermedicine.diseaseSurgeryClinical trialTreatment OutcomeLasers Gasmedicine.symptombusinessWound healingPulse lightSurgical incision
researchProduct

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound

2015

Background Hypertrophic cardiomyopathy (HCM) is the most frequent genetic cardiovascular disorder and represents one of the most common cause of heart related sudden death in young adults. Myocardial fibrosis seems to be an independant predictor of adverse events including sudden death, ventricular arrhythmias and heart failure. While late gadolinium enhancement (LGE) on Cardiac Magnetic Resonance (CMR) is actually the gold-standard to detect fibrosis, new techniques are being evaluated such as 2D strain echocardiography.

medicine.medical_specialtySudden deathFibrosisInternal medicineCardiovascular Disordermedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingRadiology Nuclear Medicine and imagingcardiovascular diseasesComputingMilieux_MISCELLANEOUSAngiologyMedicine(all)Radiological and Ultrasound Technology[ INFO.INFO-IM ] Computer Science [cs]/Medical Imagingbusiness.industryUltrasoundHypertrophic cardiomyopathymedicine.disease3. Good healthHeart failurePoster Presentationcardiovascular systemCardiologyMyocardial fibrosisCardiology and Cardiovascular Medicinebusiness
researchProduct

Exercise training intensity and connexin 43 expression in hypertrophic cardiomyopathy.

2017

• Moderate-intensity exercise improved peak oxygen consumption in hypertrophic cardiomyopathy.

medicine.medical_specialtybusiness.industryCardiomyopathyHypertrophic cardiomyopathyConnexin030229 sport sciences030204 cardiovascular system & hematologyCardiomyopathy Hypertrophicmedicine.disease03 medical and health sciences0302 clinical medicineText miningTraining intensityInternal medicineConnexin 43CardiologyMedicineHumansExercise physiologyCardiology and Cardiovascular MedicinebusinessMolecular BiologyExerciseJournal of molecular and cellular cardiology
researchProduct